BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1334240)

  • 1. A glycine antagonist reduces ischemia-induced CA1 cell loss in vivo.
    Wood ER; Bussey TJ; Phillips AG
    Neurosci Lett; 1992 Sep; 145(1):10-4. PubMed ID: 1334240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A glycine antagonist 7-chlorokynurenic acid attenuates ischemia-induced learning deficits.
    Wood ER; Bussey TJ; Phillips AG
    Neuroreport; 1993 Feb; 4(2):151-4. PubMed ID: 8453052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glycine antagonist and free radical scavenger 7-Cl-thio-kynurenate reduces CA1 ischemic damage in the gerbil.
    Pellegrini-Giampietro DE; Cozzi A; Moroni F
    Neuroscience; 1994 Dec; 63(3):701-9. PubMed ID: 7898671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycine site NMDA receptor antagonists provide protection against ischemia-induced neuronal damage in hippocampal slice cultures.
    Newell DW; Barth A; Malouf AT
    Brain Res; 1995 Mar; 675(1-2):38-44. PubMed ID: 7796152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of feeding by 7-chlorokynurenic acid, a strychnine-insensitive glycine binding site antagonist.
    Sorrels TL; Bostock E
    Brain Res; 1992 Feb; 572(1-2):265-8. PubMed ID: 1319272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo modulation of N-methyl-D-aspartate receptor-dependent long-term potentiation by the glycine modulatory site.
    Thiels E; Weisz DJ; Berger TW
    Neuroscience; 1992; 46(3):501-9. PubMed ID: 1347648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex.
    Singh L; Oles RJ; Tricklebank MD
    Br J Pharmacol; 1990 Feb; 99(2):285-8. PubMed ID: 1691674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of glycine site associated with the NMDA receptor in hippocampal long-term potentiation and acquisition of spatial memory in rats.
    Watanabe Y; Himi T; Saito H; Abe K
    Brain Res; 1992 Jun; 582(1):58-64. PubMed ID: 1386772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahippocampal administration of a glycine site antagonist impairs working memory performance of rats.
    Ohno M; Yamamoto T; Watanabe S
    Eur J Pharmacol; 1994 Feb; 253(1-2):183-7. PubMed ID: 8013546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the glycine site in the NMDA receptor is necessary for the induction of LTP.
    Bashir ZI; Tam B; Collingridge GL
    Neurosci Lett; 1990 Jan; 108(3):261-6. PubMed ID: 2154725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diazepam potentiation by glycine in pentylenetetrazol seizures is antagonized by 7-chlorokynurenic acid.
    Peterson SL
    Pharmacol Biochem Behav; 1994 Feb; 47(2):241-6. PubMed ID: 8146214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Pol J Pharmacol; 1994; 46(3):115-24. PubMed ID: 8000442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of N-methyl-D-aspartic acid receptor desensitization by glycine in mouse cultured hippocampal neurones.
    Vyklický L; Benveniste M; Mayer ML
    J Physiol; 1990 Sep; 428():313-31. PubMed ID: 2172523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant drug potentiation by glycine in maximal electroshock seizures is mimicked by D-serine and antagonized by 7-chlorokynurenic acid.
    Peterson SL
    Eur J Pharmacol; 1991 Jul; 199(3):341-8. PubMed ID: 1655484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
    Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
    Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons.
    Jarvis CR; Xiong ZG; Plant JR; Churchill D; Lu WY; MacVicar BA; MacDonald JF
    J Neurophysiol; 1997 Nov; 78(5):2363-71. PubMed ID: 9356388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors.
    Kleckner NW; Dingledine R
    Mol Pharmacol; 1989 Sep; 36(3):430-6. PubMed ID: 2550776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7-Chlorokynurenic acid, a strychnine-insensitive glycine receptor antagonist, inhibits limbic seizure kindling.
    Croucher MJ; Bradford HF
    Neurosci Lett; 1990 Oct; 118(1):29-32. PubMed ID: 2175409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indole-2-carboxylates, novel antagonists of the N-methyl-D-aspartate (NMDA)-associated glycine recognition sites: in vivo characterization.
    Rao TS; Gray NM; Dappen MS; Cler JA; Mick SJ; Emmett MR; Iyengar S; Monahan JB; Cordi AA; Wood PL
    Neuropharmacology; 1993 Feb; 32(2):139-47. PubMed ID: 8383813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.